ThrombosisChip

Price: 265 €
Timearound: 31 working days (monday to friday)

Thrombophilia, pathological tendency to develop thrombosis, is a complex state in which genetic, environmental factors and gene-environment interactions are involved. According GAIT1 study, genetic factors explain 60% of the etiology of thrombosis.


One third of patients with congenital thrombophilia have their first episode of Deep Vein Thrombosis (DVT) when there is a risk factor acquired as pregnancy. Identifying high-risk pregnant women may reduce the incidence and complications of this disease during pregnancy.


ThrombosisChip detects expected thrombophilia with a blood test, by studying 12 allelic variants in 7 genes associated with risk of venous thromboembolism (VTE) in the coagulation cascade.


> 98% specificity and sensitivity

GENETIC PANEL
Includes the 12 most relevant genetic variants of risk 

+

RISK SCORE
Unique algorithm that evaluates the risk of each factor using genetic and clinical data

+

RECOMMENDATIONS
Individualized recommendations report by Dr. José Manuel Soria



Recommended in case of:
  • Family history of thrombophilia
  • High risk pregnancies (Preeclampsia, implant failures, recurrent abortions…)